drugset / Trial / NCT00709982

A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM) /Ethinyl Estradiol (EE) in Healthy Women.

NCT00709982

RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of the study is to assess the effect of folic acid administration on the blood level and the breakdown products of OC study drug (250 mcg norgestimate\[NGM\]/35 mcg Ethinyl Estradiol \[EE\]) tablets. The effect of study drug tablet intake on the blood level of folic acid is also determined.

Timeline

Start
2005-05
Primary completion
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Norgestimate Small molecule 0.25 mg Oral
Subject ethinyl estradiol Small molecule 0.035 mg Oral
Subject folic acid Other / unclassified 1 mg Oral

Indications

No indication recorded.